AUPH

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Aurinia Pharmaceuticals (AUPH) Earnings Date & Reports

Aurinia Pharmaceuticals Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUPH is expected to report earnings to rise 950.00% to 10 cents per share on May 01

Aurinia Pharmaceuticals AUPH Stock Earnings Reports

Q1'25

Est.

$0.10

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.08

Q2'24

Est.

$0.01

Q1'24

Beat

by $0.07

The last earnings report on February 27 showed earnings per share of 0 cents, missing the estimate of 2 cents. With 1.42M shares outstanding, the current market capitalization sits at 1.12B.

View a ticker or compare two or three

Compare

AUPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AUPH
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for AUPH (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

14315 118 Avenue

Phone

+1 250 708-4272

Employees

300

Web

https://www.auriniapharma.com